Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; YI-TING LIN ; CHIH-MIN LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; YI-LING CHIEN ; Udawela M.; Gibbons A.S.; Everall I.P.; HAI-GWO HWU ; Dean B.; WEI J. CHEN | Translational psychiatry | 52 | 53 | |
2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; TZUNG-JENG HWANG ; Chan H.-Y.; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; CHIH-MIN LIU ; HAI-GWO HWU ; CHING-HUA KUO ; YI-TING LIN ; YI-LING CHIEN ; WEI J. CHEN | BMC Psychiatry | 7 | 7 | |
2020 | Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm | CHEN-CHUNG LIU ; Takeuchi H. | CNS Drugs | 10 | 8 | |
2014 | Adjuvant valproate therapy for patients with suspected mixed-depressive features. | CHEN-CHUNG LIU | 2 | 0 | ||
2019 | Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia | Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; CHIH-MIN LIU ; CHEN-CHUNG LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; YI-LING CHIEN ; YI-TING LIN ; Huang Y.-T.; Chen C.-Y.; Chandler S.D.; Faraone S.V.; Neale B.; Glatt S.J.; Tsuang M.T.; HAI-GWO HWU ; WEI J. CHEN | Biological Psychiatry | 14 | 13 | |
2015 | Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: A sibling study using tractography-based analysis of the whole brain | Wu C.-H.; TZUNG-JENG HWANG ; Chen Y.-J.; Hsu Y.-C.; Lo Y.-C.; CHIH-MIN LIU ; HAI-GWO HWU ; CHEN-CHUNG LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; CHUNG-MING CHEN ; WEN-YIH TSENG | Human Brain Mapping | 22 | 21 | |
2013 | Antipsychotic interventions in prodromal psychosis: Safety issues | CHEN-CHUNG LIU ; Liu, Chen-Chung ; Demjaha, Arsime | CNS Drugs | 23 | 18 | ![]() |
2011 | ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function | Liu C.-M.; Fann C.S.-J.; Chen C.-Y.; Liu Y.-L.; Oyang Y.-J.; Yang W.-C.; Chang C.-C.; Wen C.-C.; WEI J. CHEN ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; Faraone S.V.; Tsuang M.T.; Hwu H.-G. | Biological Psychiatry | 17 | 18 | |
2008 | Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission | CHEN-CHUNG LIU ; HUEY-LING CHIANG | CNS Drugs | 1 | 1 | |
2013 | Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: An open-label study | CHEN-CHUNG LIU ; YI-LING CHIEN ; MING-HSIEN HSIEH ; TZUNG-JENG HWANG ; Hwu H.-G.; CHIH-MIN LIU | Journal of Clinical Psychopharmacology | 16 | 13 | |
2019 | Auditory event-related potentials in antipsychotic-free subjects with ultra-high-risk state and first-episode psychosis | MING-HSIEN HSIEH ; YI-TING LIN ; YI-LING CHIEN ; TZUNG-JENG HWANG ; HAI-GWO HWU ; CHIH-MIN LIU ; CHEN-CHUNG LIU | Frontiers in Psychiatry | 21 | 18 | |
2015 | Automatic whole brain tract-based analysis using predefined tracts in a diffusion spectrum imaging template and an accurate registration strategy | Chen Y.-J.; Lo Y.-C.; Hsu Y.-C.; Fan C.-C.; TZUNG-JENG HWANG ; CHIH-MIN LIU ; YI-LING CHIEN ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; HAI-GWO HWU ; WEN-YIH TSENG | Human Brain Mapping | 46 | 48 | |
2011 | Autonomic modulation and health-related quality of life among schizophrenic patients treated with non-intensive case management | HAI-GWO HWU ; CHEN-CHUNG LIU ; CHIH-MIN LIU ; LI-REN CHANG | PLoS ONE | 17 | 15 | |
2010 | Bouffée Délirante: A Case of a Young Haitian Man in Taiwan | CHEN-CHUNG LIU | 臺灣精神醫學 | |||
2016 | A case of tardive dystonia associated with long-acting injectable paliperidone palmitate | Ma C.-H.; YI-LING CHIEN ; CHEN-CHUNG LIU ; I-MING CHEN ; Lin C.-H. | European Neuropsychopharmacology | 6 | 6 | |
2021 | Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis | CHEN-CHUNG LIU ; CHIH-MIN LIU ; YI-LING CHIEN ; YI-TING LIN ; MING-HSIEN HSIEH ; TZUNG-JENG HWANG ; HAI-GWO HWU | Frontiers in Psychiatry | 5 | 4 | |
2020 | Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase | YI-LING CHIEN ; HAI-GWO HWU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; Lin-Shiau S.-Y.; CHIH-MIN LIU | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 24 | 20 | |
2022 | Detection of advanced brain aging in schizophrenia and its structural underpinning by using normative brain age metrics | Chen C.-L.; TZUNG-JENG HWANG ; Tung Y.-H.; Yang L.-Y.; Hsu Y.-C.; CHIH-MIN LIU ; YI-TING LIN ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; YI-LING CHIEN ; HAI-GWO HWU ; Tseng W.-Y.I. | NeuroImage: Clinical | 5 | 3 | |
2016 | Development and Psychometric Properties of the Taiwan Odd-Even Number Sequencing Test: A Nonalphabetic Measure of Working Memory. | CHEN-CHUNG LIU | ||||
2018 | Development and Psychometric Properties of the Taiwan Odd–Even Number Sequencing Test: A Nonalphabetic Measure of Working Memory | Chen Y.-T.; Peng C.-Y.; Hua M.-S.; CHEN-CHUNG LIU ; Chen H.-Y.; HAI-GWO HWU | Assessment | 2 | 2 |